|
|
|
Insider
Information: |
Black Bear Offshore Master Fund Lp |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
48,695,742 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,606,754,585 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
48,695,742 |
|
|
Total
Value |
$1,606,754,585 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neose Technologies Inc |
NTEC |
10% Owner |
2005-02-18 |
3,049,996 |
|
0 |
Premium* |
|
Seachange International Inc |
SEAC |
10% Owner |
2005-04-12 |
2,091,253 |
|
0 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-07-01 |
4,186,238 |
2005-11-03 |
0 |
Premium* |
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
7,971,542 |
2006-02-24 |
0 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2008-08-27 |
12,116,463 |
2008-04-03 |
0 |
Premium* |
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-07-01 |
9,366,039 |
2009-03-12 |
0 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2009-05-31 |
9,914,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
258 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-03-05 |
4 |
B |
$7.28 |
$103,376 |
D/D |
14,200 |
6,680,948 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2007-03-05 |
4 |
B |
$5.53 |
$640,927 |
D/D |
115,900 |
9,897,137 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
officerTitle |
|
2007-03-06 |
4 |
B |
$5.53 |
$6,636 |
D/D |
1,200 |
9,898,337 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2007-03-07 |
4 |
B |
$5.60 |
$461,440 |
D/D |
82,395 |
9,980,732 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2007-03-08 |
4 |
B |
$5.67 |
$2,190,249 |
D/D |
385,800 |
10,366,532 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-03-09 |
4 |
B |
$7.28 |
$483,392 |
D/D |
66,400 |
6,747,348 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2007-03-09 |
4 |
B |
$5.66 |
$224,702 |
D/D |
39,700 |
10,406,232 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-03-14 |
4 |
B |
$7.03 |
$232,693 |
D/D |
33,100 |
6,780,448 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2007-05-04 |
4 |
B |
$5.98 |
$179,400 |
D/D |
30,000 |
10,436,232 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-05-15 |
4 |
B |
$8.03 |
$305,911 |
D/D |
38,096 |
6,818,544 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-05-16 |
4 |
B |
$8.03 |
$64,240 |
D/D |
8,000 |
6,826,544 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-07-20 |
4 |
B |
$8.70 |
$90,889 |
D/D |
10,447 |
6,836,991 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-07-24 |
4 |
B |
$8.67 |
$281,099 |
D/D |
32,422 |
6,869,413 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-07-26 |
4 |
B |
$8.51 |
$97,865 |
D/D |
11,500 |
6,880,913 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-07-27 |
4 |
B |
$8.42 |
$42,100 |
D/D |
5,000 |
6,885,913 |
2.37 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-07-30 |
4 |
B |
$8.27 |
$28,035 |
D/D |
3,390 |
6,889,303 |
2.37 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-07-31 |
4 |
B |
$8.41 |
$61,200 |
D/D |
7,277 |
6,896,580 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-08-01 |
4 |
B |
$8.34 |
$84,026 |
D/D |
10,075 |
6,906,655 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-08-06 |
4 |
B |
$8.24 |
$824 |
D/D |
100 |
6,906,755 |
2.37 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-08-08 |
4 |
B |
$8.49 |
$127,550 |
D/D |
15,000 |
6,921,755 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-08-09 |
4 |
B |
$8.35 |
$142,150 |
D/D |
17,000 |
6,938,755 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-03-28 |
4 |
B |
$28.10 |
$3,342,017 |
D/D |
118,933 |
13,780,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-03 |
4 |
B |
$30.50 |
$4,738,918 |
D/D |
155,000 |
13,935,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-07 |
4 |
B |
$31.52 |
$1,576,000 |
D/D |
50,000 |
13,985,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-08 |
4 |
B |
$30.96 |
$1,548,000 |
D/D |
50,000 |
14,035,230 |
2.45 |
- |
|
258 Records found
|
|
Page 8 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|